glp 1 with kidney disease Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog SGLT2 vs GLP-1 for Kidney
Description
Many patients wonder if GLP-1 therapy must be lifelong or if short-term use can deliver lasting results
Materials and Methods This was a single centre retrospective observational study conducted at a Swiss bariatric reference centre
A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.
Patel Helen P
Evidence shows some regain after stopping GLP-1s
GLP-1 receptor agonists work by resetting appetite signals and improving metabolic efficiency, allowing meaningful weight loss without obsessive calorie restriction
